These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6053122)

  • 21. [Value of vasodilator agents in neuropsychiatric practice and study of the indications for Praxilene].
    Bornstein S; Sère de Rivières H
    Therapeutique; 1972 Jan; 48(1):27-34. PubMed ID: 5046366
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical tests, in psychiatry, of a modifier of cerebral circulation: 1035 M.D].
    Porot M; Couadau A; Petit G; Lajoinie J
    Ann Med Psychol (Paris); 1968 Mar; 1(3):442-7. PubMed ID: 5670017
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical and experimental experience with the nicotinic acid ester 7-oxyethyltheophylline].
    Fischbach R; Haas R
    Arzneimittelforschung; 1967 Mar; 17(3):313-7. PubMed ID: 5631222
    [No Abstract]   [Full Text] [Related]  

  • 24. Results obtained with Sturgeron applied in progressive cerebral arteriosclerosis patients controlled systematically for years.
    Hunyi L
    Ther Hung; 1974; 22(1):32-4. PubMed ID: 4844929
    [No Abstract]   [Full Text] [Related]  

  • 25. [The cerebral veinous obstructions during pregnancy; thrombosis or phlebitis? Review of the literature and presentation of a case].
    Endtz LJ; Lens van Rijn JM; van Beusekom GT; Luyendijk W
    Rev Neurol (Paris); 1967 Jan; 116(1):43-59. PubMed ID: 6040644
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapeutic results with the cerebral vasodilator agent Instenon].
    Salomon K
    Wien Klin Wochenschr; 1967 Jun; 79(26):546-8. PubMed ID: 5585427
    [No Abstract]   [Full Text] [Related]  

  • 27. [Utilization of 1035 MD in cerebral ischemia disorders].
    Warot P; Petit H
    Lille Med; 1969 Feb; 14(2):78-82. PubMed ID: 5384128
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of mannitol on the intracranial volume/pressure ratio in patients with severe forms of cerebral insult].
    Solov'ev OI
    Anesteziol Reanimatol; 1984; (4):12-4. PubMed ID: 6437289
    [No Abstract]   [Full Text] [Related]  

  • 29. [Increased intracranial pressure].
    Gänshirt H
    Med Welt; 1971 Mar; 13():491-4. PubMed ID: 5563471
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cyclospasmol 400 in cerebral circulation insufficiency].
    Warot P
    Lille Med; 1973; 18(7):842-4. PubMed ID: 4603446
    [No Abstract]   [Full Text] [Related]  

  • 31. Hyperosmotic solutions and hearing Meniere's disease.
    Angelborg C; Klockhoff I; Larsen HC; Stahle J
    Am J Otol; 1982 Jan; 3(3):200-2. PubMed ID: 6798878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effects of hypertonic solution on experimental cerebral edema].
    Mizoguchi M
    Nihon Ika Daigaku Zasshi; 1982 Oct; 49(5):680-9. PubMed ID: 6815222
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pathology of occlusive cerebrovascular diseases].
    Tanaka K; Yamashita M
    No To Shinkei; 1983 Jan; 35(1):7-16. PubMed ID: 6651975
    [No Abstract]   [Full Text] [Related]  

  • 34. Noninvasive carotid artery testing and the asymptomatic bruit.
    Sergay SM
    Prim Care; 1980 Mar; 7(1):13-23. PubMed ID: 6901181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of glycerol, mannitol, and lasix on cerebrospinal fluid pressure in the acute period of a stroke].
    Misiuk NS; Kurgaev VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(8):1149-52. PubMed ID: 6797162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Extracranial-intracranial bypass by anastomosis of the temporal and sylvian arteries in cerebrovascular insufficiency and various arterial aneurysms].
    Mohr G
    Union Med Can; 1983 Nov; 112(11):1021-6, 1036. PubMed ID: 6665938
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of cyclandelate on psychological test performance in patients with cerebral vascular insufficiency.
    Smith WL; Lowrey JB; Davis JA
    Curr Ther Res Clin Exp; 1968 Dec; 10(12):613-8. PubMed ID: 4972756
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical experimentation with a combination of substances having vasodilator effects on the cerebral circulation].
    Barbi G; Tallone G
    Minerva Med; 1967 Feb; 58(13):489-91. PubMed ID: 6021620
    [No Abstract]   [Full Text] [Related]  

  • 39. [Importance of ophthalmodynamometry and ophthalmodynamography in the diagnosis of cerebral circulatory disorders].
    Felgenhauer WR
    Rev Med Suisse Romande; 1982 May; 102(5):501-18. PubMed ID: 7134707
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cerebral circulatory insufficiency. Value of a metabolic active drug].
    Girard PE; Boucher M
    Therapeutique; 1973; 49(5):397-400. PubMed ID: 4781833
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.